Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,917
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Fort Worth TX, Dallas TX, Oklahoma City OK, Houston TX,
Sponsor: Children's Oncology Group
Sex: Female
Age: 0 - 39
Code: NCT06513962
Phase3, Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Fort Worth TX, Dallas TX, Temple TX, Austin TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase2, Recruiting
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
for
Cystic Fibrosis
Location: Fort Worth TX, Dallas TX, Austin TX, Houston TX,
Sponsor: Nicole Hamblett
Sex: All
Age: 12+
Code: NCT06504589
Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
for
Glaucoma and Ocular Hypertension
Location: Fort Worth TX, Nashville TN, Sheridan CO, Peoria IL,
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT04967989
Phase3, Recruiting
Change in IOP Fluctuation After DSLT
for
Glaucoma
Location: Fort Worth TX
Sponsor: Ophthalmology Associates, Fort Worth
Sex: All
Age: 18+
Code: NCT07428668
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,